BRR OpCo’s Outset Medical OM Stock Holding History

BRR OpCo’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,060	Closed	-$5.49M	–	218
2022 Q1	$5.49M	Buy	8,060 +553	+7%	+$333K	0.58%	19
2021 Q4	$5.19M	Buy	7,507 +119	+2%	+$88K	0.56%	21
2021 Q3	$5.48M	Sell	7,388 -3,245	-31%	-$2.21M	0.62%	19
2021 Q2	$7.97M	Buy	10,633 +5,570	+110%	+$4.26M	0.88%	14
2021 Q1	$4.09M	Buy	+5,063	New	+$3.91M	0.49%	21

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BRR OpCo's OM Position: Q2 2022 in Review

BRR OpCo sold out of Outset Medical (OM) in Q2 2022, closing a stake of 8,060 shares — an estimated $5.49M sold.

BRR OpCo first reported a position in OM in Q1 2021 and held it in 5 quarters. The position peaked at $7.97M in Q2 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

BRR OpCo reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
BRR OpCo sold 8,060 Outset Medical shares in Q2 2022, an estimated $5.49M.
BRR OpCo first reported a position in Outset Medical in Q1 2021 and held it in 5 quarters.
BRR OpCo's Outset Medical position peaked at $7.97M in Q2 2021.
149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on BRR OpCo's 13F filing for Q2 2022, filed 4 Aug 2022.